TDC
DGX icon

Thompson Davis & Co’s Quest Diagnostics DGX Stock Holding History

Thompson Davis & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-16
Closed -$1K – 1105
2016
Q2 		$1K Hold
16
– – ﹤0.01% 1009
2016
Q1 		$1K Hold
16
– – ﹤0.01% 1006
2015
Q4 		$1K Sell
16
-5
-24% -$336 ﹤0.01% 1077
2015
Q3 		$1K Hold
21
– – ﹤0.01% 1079
2015
Q2 		$2K Sell
21
-3
-13% -$222 ﹤0.01% 1072
2015
Q1 		$2K Sell
24
-4
-14% -$286 ﹤0.01% 1067
2014
Q4 		$2K Buy
28
+14
+100% +$883 ﹤0.01% 1093
2014
Q3 		$1K Buy
+14
New +$863 ﹤0.01% 1101

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Thompson Davis & Co's DGX Position: Q3 2016 in Review

Thompson Davis & Co sold out of Quest Diagnostics (DGX) in Q3 2016, closing a stake of 16 shares — an estimated $1K sold.

Thompson Davis & Co first reported a position in DGX in Q3 2014 and held it in 8 quarters. The position peaked at $2K in Q2 2015. 560 funds tracked by Wall St. Rank hold DGX as of Q3 2016.

  • Thompson Davis & Co reported no remaining Quest Diagnostics position as of Q3 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 16 Quest Diagnostics shares in Q3 2016, an estimated $1K.
  • Thompson Davis & Co first reported a position in Quest Diagnostics in Q3 2014 and held it in 8 quarters.
  • Thompson Davis & Co's Quest Diagnostics position peaked at $2K in Q2 2015.
  • 560 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2016.

Based on Thompson Davis & Co's 13F filing for Q3 2016, filed 8 Nov 2016.